RESUMO
BACKGROUND: COVID-19 quickly became a serious public health problem worldwide, with serious economic and social repercussions. Homeopaths around the world have been studying to find a genus epidemicus (GE) medicine that might help in the prevention and treatment of this disease. OBJECTIVE: To compare the incidence of COVID-19 between employees who received or did not receive a homeopathic GE medicine for disease prevention. METHODS: Retrospective cohort analysis. The study population comprised all employees of a service sector company in São Paulo, Brazil, and followed up by the corporate Occupational Health department. Intervention consisted of administering Arsenicum album 30cH in a one-weekly dose. Primary outcome was incidence of COVID-19 during 3-months' follow-up (April to July, 2020). RESULTS: We analyzed 1,642 of 1,703 employees without previous diagnosis of COVID-19 at onset of the study period: 53.34% of employees were referred to telework at home and did not receive intervention (Group 1, G1); 24.66% remained working on-premises in the state of São Paulo and received the intervention (Group 2, G2); 21.98% remained working on company premises in other states and did not receive intervention (Group 3, G3). Incidence rate of COVID-19 was respectively 13.35%, 0.74%, and 67.87% (p < 0.001). The odds ratio of being infected in (1) G3 versus G1 was 13.70 (95% confidence interval [CI], 10.21 to 18.39), (2) G3 versus G2 was 283.02 (95% CI, 88.98 to 900.18), and (3) G1 versus G2 was 20.66 (95% CI, 6.53 to 65.39). LIMITATIONS: The present is a retrospective analysis of a real-world experience. We could not ensure direct observed treatment, and neither could we control adherence to general prevention measures outside company premises. CONCLUSION: The incidence of COVID-19 was significantly lower amongst on-premises employees who received the GE medication in comparison to workers who did not receive the intervention (those either at other company premises or teleworking at home).
Assuntos
COVID-19 , Homeopatia , Materia Medica , Brasil/epidemiologia , COVID-19/epidemiologia , COVID-19/prevenção & controle , Humanos , Materia Medica/uso terapêutico , Estudos RetrospectivosRESUMO
Relato do caso: Sra. M., 57 anos, há 3 dias apresentando dores agudas na uretra, em queimação, ao urinar, e coceira após; dores no baixo ventre, em topografia de bexiga, antes e durante a micção; desejo muito aumentado de urinar, mas a cada ida ao banheiro, apenas um pouco de urina era expelida; indisposição geral; bastante irritada,nervosa, ralhando severamente com os familiares, especialmente logo após a micção; hipersensível mesmo a pequenos estímulos, como luz, ruídos, conversa das pessoas; normalmente calorenta, mas agora abrigando-se do frio até de modo excessivo masnão apresentava febre. Apetite diminuído, mas com sede. Sem outras queixas. Ao exame físico, dor à palpação abdominal em região suprapúbica. Abdome inocente.
Assuntos
Infecções Urinárias/terapiaRESUMO
Este trabalho tem o objetivo de prestar uma homenagem a este pernambucano que foi um dos maiores vultos da homeopatia brasileira.
RESUMO
Este trabalho tem o objetivo de prestar uma homenagem a este pernambucano que foi um dos maiores vultos da homeopatia brasileira.(AU)
